Abstract
Specific chromosomal aberrations are associated with specific types of cancer (for review see ref. 1). The distinctiveness of each association has led to the belief that these chromosomal aberrations are clues to oncogenic events or to the state of differentiation in the malignant cell type2–6. Malignancies of T lymphocytes demonstrate such an association characterized most frequently by structural translocations or inversions of chromosomes 7 and 14 (refs 7–9). Analyses of these chromosomally marked tumours at the molecular level may therefore provide insight into the aetiology of the cancers as well as the mechanisms by which chromosomes break and rejoin. Here we report such an analysis of the tumour cell line SUP-T1 derived from a patient with childhood T-cell lymphoma carrying an inversion of one chromosome 14 between bands qll.2 and q32.3, that is10, inv(14) (qll.2; q32.2). These are the same chromosomal bands to which the T-cell receptor α-chain11,12 (14qll.2) and the immunoglobulin heavy-chain locus13 (14q32.3) have been assigned. Our analysis reveals that this morphological inversion of chromosome 14 was mediated by a site-specific recombination event between an immunoglobulin heavy-chain variable region (Ig VH) and a T-cell receptor (TCR) α-chain joining segment (TCR Jα). S1 nuclease analysis shows that this hybrid gene is transcribed into poly(A)+ RNA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yunis, J. J. Science 221, 227–236 (1983).
Klein, G. Nature 294, 313–318 (1981).
Yunis, J. J. & Soreng, A. L. Science 226, 1199–1204 (1984).
Chaganti, R. S. K. Blood 62, 515–524 (1983).
Kirsch, I. R., Brown, J. A., Lawrence, J., Korsmeyer, S. J. & Morton, C. C. Cancer Genet. Cytogenet. 18, 159–172 (1985).
Kirsch, I. R. et al. in Genes and Cancer, 583–587 (Liss, New York, 1984).
Zech, L., Hammarstrom, L. & Smith, C. I. E. Int. J. Cancer 32, 431 (1981).
Zech, L. et al. Nature 308, 858–860 (1984).
Hecht, F., Morgan, R., Gemmill, R. M., Hecht, B. K. M. & Smith, S. D. New Engl. J. Med. 313, 758–759 (1985).
Hecht, F., Morgan, R., Hecht, B. K. M. & Smith, S. D. Science 226, 1445–1447 (1984).
Croce, C. M. et al. Science 227, 1044–1047 (1985).
Caccia, N. et al. J. exp. Med. 161, 1255–1260 (1985).
Kirsch, I. R., Morton, C. C., Nakahara, K. & Leder, P. Science 216, 301–303 (1982).
Yoshikai, Y. et al. Nature 316, 837–840 (1985).
Erikson, J., Williams, D. L., Finan, J., Nowell, P. C. & Croce, C. M. Science 229, 784–786 (1985).
Lewis, W. H., Michalopoulos, E. E., Williams, D. L., Minden, M. D. & Mak, T. W. Nature 317, 544–546 (1985).
Leder, P. Scient. Am. 246 (5), 102–115 (1982).
Kabat, E. A., Wu, T. T., Bilofsky, H., Reid-Miller, M. & Perry, H. in Sequences of Proteins of Immunological Interest, 109–110 (US Department of Health and Human Services, Washington, DC, 1983).
Yanagi, Y., Chan, A., Chin, B., Minden, M. & Mak, T. W. Proc. natn. Acad. Sci. U.S.A. 82, 3430–3434 (1985).
McBride, O. W. et al. Nucleic Acids Res. 10, 8155–8170 (1982).
Erikson, J., Finan, J., Nowell, P. C. & Croce, C. M. Proc. natn. Acad. Sci. U.S.A. 79, 5611–5615 (1982).
Berk, A. & Sharp, P. Cell 12, 721–732 (1977).
Max, E. E., Seidman, J. G. & Leder, P. Proc. natn. Acad. Sci. U.S.A. 76, 3450–3454 (1979).
Sakano, H., Huppi, K., Heinrich, G. & Tonegawa, S. Nature 280, 288–294 (1979).
Sakano, H., Maki, R., Kurosawa, Y., Roder, W. & Tonegawa, S. Nature 286, 676–683 (1980).
Early, P., Huang, H., Davis, M., Calame, K. & Hood, L. Cell 19, 981–992 (1980).
Sakano, H., Kurosawa, Y., Weigert, M. & Tonegawa, S. Nature 290, 562–565 (1981).
Hayday, A. C. et al. Nature 316, 828–832 (1985).
Winoto, A., Mjolsness, S. & Hood, L. Nature 316, 832–836 (1985).
Chien, Y., Gascoigne, N. R. J., Kavaler, J., Lee, N. E. & Davis, M. M. Nature 309, 322–326 (1984).
Gascoigne, N. R. J., Chien, Y., Becker, D. M., Kavaler, J. & Davis, M. M. Nature 310, 387–391 (1984).
Tsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C. & Croce, C. M. Science 226, 1097–1099 (1984).
Bakhshi, A. et al. Cell 41, 899–906 (1985).
Tsujimoto, Y. et al. Nature 315, 340–343 (1985).
McCaw, B. K., Hecht, F., Harnden, D. G. & Teplitz, R. L. Proc. natn. Acad. Sci. U.S.A. 72, 2071–2075 (1975).
Kohn, P. H., Whang-Peng, J. & Levis, W. R. Cancer Genet. Cytogenet. 6, 289–302 (1982).
Taylor, A. M. R. in Ataxia-telangiectasia. A Cellular Link Between Cancer Neuropathy and Immunodeficiency (eds Bridges, B. A. & Harnden, D. G.) 53–81 (Wiley, New York, 1982).
Southern, E. M. J. molec. Biol. 98, 503–517 (1975).
Sanger, F., Nicklen, S. & Coulson, A. R. Proc. natn. Acad. Sci. U.S.A. 74, 5463–5467 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Denny, C., Yoshikai, Y., Mak, T. et al. A chromosome 14 inversion in a T-cell lymphoma is caused by site-specific recombination between immunoglobulin and T-cell receptor loci. Nature 320, 549–551 (1986). https://doi.org/10.1038/320549a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/320549a0
This article is cited by
-
Identification of functional nucleotide and haplotype variants in the promoter of the CEBPE gene
Journal of Human Genetics (2013)
-
Chromosomal translocations in human cancer
Nature (1994)
-
Deletion mapping of the mouse ornithine decarboxylase-related locus Odc-rs8 within Igh-V
Mammalian Genome (1992)
-
Chromosomal localization of HTLV-1 viral integration sites using in situ hybridization: detection of a novel IL2R fragment
Molecular and General Genetics MGG (1992)
-
Tissue specificity of chromosomal rearrangements in ataxia-telangiectasia
Human Genetics (1989)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.